Exelixis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. 

CEO
Michael M. Morrissey
CEOMichael M. Morrissey
Employees
1,147
Employees1,147
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
1994
Founded1994
Employees
1,147
Employees1,147

EXEL Key Statistics

Market cap
10.40B
Market cap10.40B
Price-Earnings ratio
19.01
Price-Earnings ratio19.01
Dividend yield
Dividend yield
Average volume
2.07M
Average volume2.07M
High today
$39.70
High today$39.70
Low today
$38.50
Low today$38.50
Open price
$39.42
Open price$39.42
Volume
3.12M
Volume3.12M
52 Week high
$49.62
52 Week high$49.62
52 Week low
$25.17
52 Week low$25.17

EXEL News

Simply Wall St 5d
Exelixis: Evaluating Valuation After Recent Strong Share Price Gains

Exelixis (EXEL) stock has seen some attention from investors recently, gaining more than 11% over the past month and up 22% year to date. The company’s performa...

Exelixis: Evaluating Valuation After Recent Strong Share Price Gains

Analyst ratings

57%

of 21 ratings
Buy
57.1%
Hold
42.9%
Sell
0%

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.